Clinical Trials Sponsored by Bionor Pharma

Total 8487 results

Conor Medsystems
Getz Pharma

Terminated

Multi-Center Clinical Trial: Evaluation of Effectiveness and Safety

Coronary Disease

Japan
University of Copenhagen
Arla Foods; Hoeng Fonden; Bionor Pharma

Unknown

Effect of UHT Treated Milk on Blolipid Profile (UHT)

To Investigate the Effect of UHT Treated Milk Versus Pasteurised Milk on Bloodlipid Profil

Denmark
Bionor Immuno AS

Completed

Re-boosting of HIV-1 Infected Subjects With Vacc-4x (Re-boost)

HIV-1 Infection

United States, Spain, Germany, Italy, United Kingdom
Bionor Immuno AS

Completed

Immunogenicity Study of Vacc-4x Versus Placebo in Patients Infected With HIV

HIV I Infection

Germany, United States, Spain, United Kingdom, Italy
Bionor Immuno AS

Completed

Immunotherapy With Vacc-C5 With Adjuvant GM-CSF or Alhydrogel in HIV-1-infected Subjects on ART

HIV-1 Infection

Norway
Bionov

Unknown

Evaluation of SODB® in Metabolic Adaptations in Overweight Women (SORESCAL)

Overweight
Bionov

Unknown

Evaluation of SODB® (Superoxide Dismutase by Bionov®) in the Physical Condition Improvement in Healthy Subjects (MELORUN560)

Healthy Volunteers
Bionov
Seppic

Completed

Multicentre, Double-blind Study Versus Placebo on Impact and Safety of Extramel® 140 IU on Perceived Stress, Physical and Intellectual Fatigue, Pain Perception if Present, and the Impact on the Quality of Life (Ex Stress II)

Quality of Life | Pain | Fatigue | Life Stress
Bionov
BioFortis

Completed

Evaluation of the Effects of a Food Supplementation on the Improvement of Cognitive Functions in Healthy Seniors (BioMind)

Healthy Subjects

France
Bionor Immuno AS
Celgene Corporation

Completed

Vacc-4x + Lenalidomide vs. Vacc-4x +Placebo in HIV-1-infected Subjects on Antiretroviral Therapy (ART) (IMID)

HIV-1 Infection

Germany
Bionor Immuno AS
Celgene Corporation

Completed

Safety and Efficacy of Romidepsin and the Therapeutic Vaccine Vacc-4x for Reduction of the Latent HIV-1 Reservoir (REDUC)

HIV I Infection

Denmark
Bionou Research, S.L.

Recruiting

Clinical Trial to Evaluate the Effect of a Probiotic Mixture on the Rosacea Evolution

Rosacea | Rosacea, Papulopustular | Rosacea Papular Type

Spain
Bionos Biotech S.L.

Active, not recruiting

Clinical Evaluation of the Magnesium Absorption Kinetics in Human Plasma Upon Oral Intake of Magnesium-based Products

Healthy Volunteers

Spain
Bionos Biotech S.L.

Completed

Bioavailability of Different Collagen-based Treatments After Oral Intake

Healthy Volunteers

Spain
Bionos Biotech S.L.

Completed

Evaluation of the Effects of DracoBelle Nu in Skin Health After Oral Intake

Healthy Volunteers

Spain
Bionou Research, S.L.

Completed

Clinical Trial to Evaluate the Effect of a Probiotic in Acne

Acne Vulgaris | Acne

Spain
Bionou Research, S.L.

Completed

A Pilot Study to Evaluate the Effect of a Probiotic Mixture in Acne

Acne Vulgaris | Acne

Spain
Bionovo

Unknown

A Study of MF101 in Postmenopausal Women (HERBA)

Vasomotor Symptoms | Hot Flushes

United States
Bionovo

Terminated

Phase I Study to Evaluate the Safety and Efficacy of MF101 as Well as the Pharmacokinetics of Its Key Active Components

Healthy

United States
Hospital Universitario Infanta Leonor
Kern Pharma, S.L.; Fundación para la Investigación e Innovación Biomédica del...

Recruiting

DEXamethasone EARLY Administration in Hospitalized Patients With Covid-19 Pneumonia (EARLYDEXCoV2)

COVID-19 | Pneumonia, Viral | Acute Respiratory Distress Syndrome

Spain
Bionovo

Unknown

A Clinical Trial Assessing Safety of MF101 for Hot Flushes

Hot Flashes

United States
Bionovo

Completed

Sleep Quality in CHIMES (MF101)

Sleep Quality | Menopausal Symptoms

United States
Bionovo

Completed

A Phase I/II Clinical Trial Assessing Safety and Efficacy of BZL101 for Metastatic Breast Cancer

Metastatic Breast Cancer
Bionovo

Unknown

A Clinical Trial Assessing Safety and Efficacy of BZL101 for Metastatic Breast Cancer

Metastatic Breast Cancer

United States
Bionovo

Unknown

VG101 Phase I/II to Treat Vulvar and Vaginal Atrophy in Post-Menopausal Women

Vaginal Atrophy | Vulvar Atrophy

United States
Bionovo

Completed

Clinical Trial Assessing Toxicity and Efficacy of MF101 for Hot Flashes

Hot Flashes

United States
Biocon Biologics Inc.
MEDA Pharma GmbH & Co. KG; Mylan Inc.; IQVIA Pvt. Ltd

Completed

Hulio Interchangeability to Humira®, Comparing Pharmacokinetics, Efficacy, Safety and Immunogenicity

Moderate Chronic Plaque Psoriasis | Severe Chronic Plaque Psoriasis

Bulgaria, Czechia, Estonia, Poland
Biocon Limited

Completed

Efficacy and Safety of Itolizumab in COVID-19 Complications

Covid19 | Acute Respiratory Distress Syndrome | Cytokine Release Syndrome

India
Bioniz Therapeutics

Completed

A Dose-Ranging Study of IV BNZ-1 in LGL Leukemia or Refractory CTCL

LGL Leukemia | CTCL

United States
Biocon Limited

Completed

Comparison of Insulin Tregopil (IN-105) With Insulin Aspart in Type 2 Diabetes Mellitus Patients

Type2 Diabetes Mellitus

India
Biocon Limited

Completed

Effect of Dosing Time and Meal on IN-105 (Insulin Tregopil) PK and PD

Type 2 Diabetes Mellitus
Biocon Limited

Terminated

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Insulin (IN-105) in Type 1 Diabetes Patients

Type 1 Diabetes Mellitus

India
Biocon Biologics UK Ltd

Active, not recruiting

Comparison of Efficacy, Pharmacodynamics, Safety, and Immunogenicity Between Bmab 1000 and Prolia® in Postmenopausal Women With Osteoporosis (DEVOTE)

Postmenopausal Women With Osteoporosis

United Kingdom
Biocon Biologics UK Ltd

Not yet recruiting

Efficacy and Safety of the Proposed Biosimilar Pertuzumab (PERT-IJS) Versus EU-Perjeta® Along With Trastuzumab and Chemotherapy (Carboplatin and Docetaxel) as Neoadjuvant Treatment in Chemotherapy naïve Patients With Early Stage or Locally Advanced HR Negative and HER2 Positive Breast Cancer

HR Negative HER2 Positive Early Breast Cancer or Locally Advanced Breast Cancer Patients
Biocon Biologics UK Ltd

Active, not recruiting

Comparing Efficacy and Safety of Bmab 1200 and Stelara in Patients With Moderate to Severe Chronic Plaque Psoriasis (STELLAR-2)

Moderate to Severe Chronic Plaque Psoriasis

United States
Bionou Research, S.L.
Biopolis S.L.

Recruiting

Clinical Trial to Evaluate the Effect of a Probiotic Mixture in the Treatment of Atopic Dermatitis in Children

Atopic Dermatitis

Spain
Bionode, LLC

Unknown

Clinical Study Of The Bionode System In Subjects With Elevated IOP

Unmedicated IOP Before and After Treatment

Canada
R-Pharm
Covance; Cromos Pharma LLC

Withdrawn

Study of the Efficacy and Safety of a Single Administration of Olokizumab vs. Placebo in Addition to Standard Treatment in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19).

COVID-19
Bioithas SL
Bionou Research, S.L.

Completed

Clinical Trial to Evaluate Effectiveness of a Probiotic Preparation Administered to Patients With Alopecia Areata

Alopecia Areata

Spain
Biocon Biologics UK Ltd
Biotrial

Completed

Comparison of Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Bmab 1000 and Prolia® in Normal Healthy Volunteers: DENARIUS: DENosumab Pharmacokinetic equivAlence tRIal in Healthy volUnteerS (DENARIUS)

Healthy Volunteers

United States
Oslo University Hospital
Eurocine Vaccines AB; Bionor Immuno AS

Completed

Intranasal Modified Vacc-4x Gag Peptides With Endocine as Adjuvant

HIV Infection

Norway
UCB BIOSCIENCES, Inc.
R-Pharm

Terminated

Open-label Study to Assess the Safety and Efficacy of CDP6038 (Olokizumab) in Patients Who Completed RA0056

Rheumatoid Arthritis

United States, Belgium, United Kingdom
AJU Pharm Co., Ltd.
OM Pharma SA

Recruiting

The Efficacy and Safety of OM-89 in Patients With Recurrent Chronic Prostatitis/Chronic Pelvic Pain Syndrome

Chronic Prostatitis With Chronic Pelvic Pain Syndrome | Chronic Prostatitis | Chronic Pelvic Pain Syndrome

Korea, Republic of
UCB BIOSCIENCES, Inc.
R-Pharm

Terminated

The Long-term Safety and Efficacy of CDP6038 (Olokizumab) With Active Rheumatoid Arthritis

Rheumatoid Arthritis

Japan, Korea, Republic of, Taiwan
Yuria-Pharm
Pharmaxi LLC

Completed

Epidemiological Study of the COVID-2019 in Participating Organizations.

Covid19

Ukraine
Equillium
Biocon Limited

Recruiting

A Study of Itolizumab in Combination With Corticosteroids for the First-Line Treatment of Acute Graft Versus Host Disease (EQUATOR)

Graft Versus Host Disease | GVHD | aGVHD | Acute-graft-versus-host Disease | Acute GVHD

United States, Korea, Republic of, Israel, Spain, Germany, Belgium, Italy, Australia, France, Canada, Portugal
Equillium
Biocon Limited

Withdrawn

A Study to Evaluate the Efficacy and Safety of Itolizumab in Subjects Hospitalized With COVID-19 (EQUINOX)

Coronavirus

Colombia
Bioniz Therapeutics
Celerion

Completed

A First-in-Human Study of BNZ132-1-40

Healthy

United States
BioPro Medical Ltd

Completed

Efficacy Study of Vaginal Mifepristone to Treat Uterine Fibroids

Uterine Fibroid | Vaginal Bleeding.

Israel
Bionic Sight LLC

Recruiting

BS01 in Patients With Retinitis Pigmentosa

Retinitis Pigmentosa

United States

3

Subscribe